MitoQ
Sponsors
Antipodean Pharmaceuticals, Inc., University of Delaware, University of Colorado, Boulder, University of Nebraska, Virginia Commonwealth University
Conditions
AgingAlzheimer Disease, Early OnsetAmyotrophic Lateral Sclerosis ALSBlood PressureCardiovascular DiseasesCardiovascular Risk FactorChronic Kidney DiseaseChronic Obstructive Pulmonary Disease
Early Phase 1
Mitochondrial Derived Reactive Oxygen Species on Cardiovascular Health in Chronic Obstructive Pulmonary Disease (COPD)
TerminatedNCT05605548
Start: 2023-02-16End: 2024-07-30Updated: 2025-02-27
MitoQ and Exercise Effects on Vascular Health
Active, not recruitingNCT05686967
Start: 2023-01-16End: 2025-11-30Updated: 2025-03-25
Phase 2
A Trial of MitoQ for the Treatment of People With Parkinson's Disease
CompletedNCT00329056
Start: 2006-05-31End: 2007-11-30Updated: 2010-07-21
MARVEL: Mitochondrial Anti-oxidant Therapy to Resolve Inflammation in Ulcerative Colitis
Active, not recruitingNCT04276740
Start: 2022-05-31End: 2026-11-30Updated: 2026-01-13
Mitochondrial-targeted Antioxidant Supplementation for Improving Age-related Vascular Dysfunction in Humans
Active, not recruitingNCT04851288
Start: 2021-04-02End: 2026-12-31Target: 112Updated: 2025-11-12
Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis
WithdrawnNCT05539625
Start: 2025-09-01End: 2026-10-31Updated: 2026-01-09
MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
RecruitingNCT06191965
Start: 2024-06-01End: 2027-01-31Target: 100Updated: 2025-09-25
Effects of an Antioxidant Supplement on Blood Vessel Health
RecruitingNCT06424756
Start: 2024-07-01End: 2030-03-31Target: 60Updated: 2024-12-09
ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments
CompletedNCT06429059
Start: 2024-06-12End: 2025-06-24Updated: 2025-09-26
Phase 4
Unknown Phase
The Efficacy of Oral Mitoquinone (MitoQ) Supplementation for Improving Physiological in Middle-aged and Older Adults
CompletedNCT02597023
Start: 2015-09-30End: 2017-12-31Updated: 2018-04-12
Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease Patients
CompletedNCT03506633
Start: 2018-09-05End: 2022-01-17Updated: 2025-04-01
Effects of Mitochondrial-targeted Antioxidant on Mild Cognitive Impairment (MCI) Patients
WithdrawnNCT03514875
Start: 2019-11-11End: 2022-07-18Updated: 2023-08-15
Chronic Kidney Disease and Heart Failure With Preserved Ejection Fraction: The Role of Mitochondrial Dysfunction
CompletedNCT03960073
Start: 2019-07-31End: 2022-09-30Updated: 2022-12-19
Concentration of MitoQ in Human Skeletal Muscle
NCT04098510
Start: 2019-09-08End: 2020-09-30Target: 10Updated: 2019-09-23
Effect of MitoQ on Platelet Function and Reactive Oxygen Species Generation in Patients With Sickle Cell Anemia
RecruitingNCT04109820
Start: 2020-03-01End: 2027-06-30Target: 15Updated: 2025-06-19
The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function
RecruitingNCT04334135
Start: 2020-10-02End: 2025-08-31Target: 60Updated: 2024-05-29
Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle
CompletedNCT04558190
Start: 2020-09-02End: 2021-11-01Updated: 2021-12-02
Mitochondria Oxidative Stress and Vascular Health Study
CompletedNCT05561556
Start: 2022-12-06End: 2025-09-26Updated: 2025-09-29
MitoQ & Cardiopulmonary Responses During Exercise
CompletedNCT06069245
Start: 2022-09-14End: 2023-04-30Updated: 2023-10-05